WASHINGTON, Oct. 9 -- The U.S. Department of Health & Human Services issued the following press release:
The U.S. Department of Health and Human Services (HHS) provided a new recommendation to the Drug Enforcement Administration (DEA) that establishes science-based thresholds for 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI), potent opioid compounds associated with products marketed as kratom.
The Department of Justice today announced (https://www.justice.gov/opa/pr/department-justice-announces-updates-emergency-scheduling-actions-7-oh-and-related-opioid) that DEA issued new Notices of Intent reflecting HHS' updated scientific analysis and recommendations, including a new Notice of Intent for 7-OH and MGPI incorporating...